Abstract
Memapsin 2 (β-secretase) is one of two proteases that cleave the β-amyloid precursor protein (APP) to produce the 40-42 residue amyloid-β peptide (Aβ) in the human brain, a key event in the progression of Alzheimer's disease. On the basis of the X-ray crystal structure of our lead inhibitor (2, OM99-2 with eight residues) bound to memapsin, we have reduced the molecular weight and designed potent memapsin inhibitors. Structure-based design and preliminary structure-activity studies have been presented.
Original language | English (US) |
---|---|
Pages (from-to) | 2865-2868 |
Number of pages | 4 |
Journal | Journal of Medicinal Chemistry |
Volume | 44 |
Issue number | 18 |
DOIs | |
State | Published - Aug 30 2001 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery